Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK

References

• DurrieDStahlJA randomized clinical evaluation of the safety of Systane Lubricant Eye Drops for the relief of dry eye symptoms following LASIK refractive surgeryClin Ophthalmol20082497397919668456
   PubMedGoogle Scholar
• SalomaoMQAmbrosioRJrWilsonSEDry eye associated with laser in situ keratomileusis: mechanical microkeratome versus femtosecond laserJ Cataract Refract Surg200935101756176019781472
   PubMed Web of Science ®Google Scholar
• AbelsonMProtzkoEShapiroAA randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitisClin Ophthalmol20071217718219668507
   PubMedGoogle Scholar
• SandovalHPFernandez de CastroLEVromanDTSolomonKDA review of the use of ketorolac tromethamine 0.4% in the treatment of post-surgical inflammation following cataract and refractive surgeryClin Ophthalmol20071436737119668513
   PubMedGoogle Scholar
• ChoHWolfKJWolfEJManagement of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solutionClin Ophthalmol2009319921019668566
   PubMedGoogle Scholar
• MillerDReview of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infectionsClin Ophthalmol200821779119668391
   PubMedGoogle Scholar
• BucciFAJrAmicoLMEvansREAntimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgeryEye Contact Lens2008341394218180682
   PubMed Web of Science ®Google Scholar
• MoshirfarMChewJWernerLComparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyesGraefes Arch Clin Exp Ophthalmol2008246101455146118642018
   PubMed Web of Science ®Google Scholar
• WilliamsKKMcCartneyMDRiceRLThe effects of moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3% treatment on corneal wound healing in pigmented rabbits following anterior keratectomyVet Ophthalmol200811532733419046293
   PubMed Web of Science ®Google Scholar
• TsaiTHChenWLHuFRComparison of fluoroquinolones: cytotoxicity on human corneal epithelial cellsEye201024590991719648900
   PubMed Web of Science ®Google Scholar
• ScoperSVReview of third- and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacyAdv Ther2008251097999418836691
   PubMed Web of Science ®Google Scholar
• LevineJMNoeckerRJLaneLCComparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosingJ Cataract Refract Surg200430102177218215474833
   PubMed Web of Science ®Google Scholar
• DonnenfeldRSPerryHDSolomonRA comparison of gatifloxacin to ciprofloxacin in the prophylaxis of Streptococcus pneumoniae in rabbits in a LASIK modelEye Contact Lens2006321465016415694
   PubMedGoogle Scholar
• AkramMShyumSBGauharSDevelopment of new ophthalmic suspension prednisolone acetate 1%Pak J Pharm Sci201023214915420363691
   PubMed Web of Science ®Google Scholar
• AlioJLPerez-SantonjaJJTervoTPostoperative inflammation, mkicrobial complications, and wound healing following laser in situ keratomileusisJ Refract Surg200016552353811019867
   PubMed Web of Science ®Google Scholar
• Asano-KatoNTodaITsuruyaTDiffuse lamellar keratitis and flap margin epithelial healing after laser in situ keratomileusisJ Refract Surg2003191303312553602
   PubMed Web of Science ®Google Scholar
• BuhrenJKohnenTCorneal wound healing after laser in situ keratomileusis flap lift and epithelial abrasionJ Cataract Refract Surg200329102007201214604726
   PubMed Web of Science ®Google Scholar
• JinGJLyleWAMerkleyKHLate-onset idiopathic diffuse lamellar keratitis after laser in situ keratomileusisJ Cataract Refract Surg200531243543715767170
   PubMed Web of Science ®Google Scholar
• HaddenOBPatelDGrayTBMultifocal lamellar keratitis following laser in situ keratomileusisJ Cataract Refract Surg200733114414717189812
   PubMed Web of Science ®Google Scholar
• MoshirfarMWellingJDFeizVInfectious and noninfectious keratitis after laser in situ keratomileusis: occurrence, management, and visual outcomesJ Cataract Refract Surg200733347448317321399
   PubMed Web of Science ®Google Scholar
• SridharMSRaoSKVajpayeeRBComplications of laser-in-situ-keratomileusisIndian J Ophthalmol200250426528212532491
   PubMedGoogle Scholar
• HolzerMPSandovalHPVargasLGCorneal flap complications in refractive surgery: Part 2: postoperative treatment of diffuse lamellar keratitis in an experimental animal modelJ Cataract Refract Surg200329480380712686253
   PubMed Web of Science ®Google Scholar
• KarimianFYurdkhaniHAnisianATopical steroids for prevention of diffuse lamellar keratitis following LASIKIran J Ophthalmic Res200722119123
   Google Scholar
• ShahMNMisraMWihelmusKRKochDDDiffuse lamellar keratitis associated with epithelial defects after laser in situ keratomileusisJ Cataract Refract Surg20002691312131811020615
   PubMed Web of Science ®Google Scholar
• NgEYThinagaranSKinsellaFO’KeefeMProphylaxis of diffuse lamellar keratitis with intraoperative interface steroids in LASIKJ Refract Surg200925330631119370827
   PubMed Web of Science ®Google Scholar
• RenardGAdenisJPRoulandJFEfficacy and tolerability of a combination of indomethacin and gentamicin for preventing inflammation after cataract surgeryJ Fr Ophthalmol19961911689695
   Google Scholar
• Van EndtJJVeraartHGKramerRA comparison of two ophthalmic steroid-antibiotic combinations after cataract surgeryEur J Ophthalmol1997721441489243217
   PubMedGoogle Scholar
• ShepherdWFFsadniMGRajPSDiclofenac-gentamicin versus Gentamicin Study GroupA clinical evaluation of diclofenac-gentamicin combination eye drops in the control of inflammation after cataract surgeryOcul Immunol Inflamm19986113189798189
   PubMed Web of Science ®Google Scholar
• BarraquerRIAlvarez de ToledoJPMontaneDFixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution for inflammation after cataract surgery: a randomized, comparative, active treatment-controlled trialEur J Ophthalmol1998831731789793772
   PubMed Web of Science ®Google Scholar
• RussoSPapaVDi BellaADexamethason-netilmicin: a new ophthalmic steroid-antibiotic combination. Efficacy and safety after cataract surgeryEye2007211586416273088
   PubMed Web of Science ®Google Scholar
• NotivolRAminDWhitlingAProphylactic effectiveness of tobramycin-dexamethasone eye drops compared with tobramycin/vehicle eye drops in controlling post-surgical inflammation in cataract patients: prospective, randomised, double-masked, two-arm, parallel-group, placebo-controlled, multicentre studyClin Drug Invest2004249523533
   Web of Science ®Google Scholar
• FreitasLLSorianoEMuccioliCEfficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trialCurr Med Res Opin200723123123313017980093
   PubMed Web of Science ®Google Scholar
• GrossRLSullivanEKWellsDTPooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%Clin Ophthalmol20071331732219668487
   PubMedGoogle Scholar
• HollandEJBartlettJDPaternoMREffects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteersCornea2008271505518245967
   PubMed Web of Science ®Google Scholar
• ShinJHLeeHBParkHYComparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomyCornea201029111236124020697276
   PubMed Web of Science ®Google Scholar
• DiestelhorstMAspacherFKonenWEffect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric studyGraefes Arch Clin Exp Ophthalmol199223054514531521812
   PubMed Web of Science ®Google Scholar
• OstrovCSSirkinSRDeutschWEKetorolac, prednisolone, and dexamethasone for postoperative inflammationClin Ther19971922592729152565
   PubMed Web of Science ®Google Scholar
• SimoneJNPendeltonRAJenkinsJEComparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgeryJ Cataract Refract Surg199925569970410330648
   PubMed Web of Science ®Google Scholar
• StruckHGBariszlovichAComparison of 0.1% dexamethasone phosphate eye gel (Dexagel) and 1% prednisolone acetate eye suspension in the treatment of post-operative inflammation after cataract surgeryGraefes Arch Clin Exp Ophthalmol20012391073774211760033
   PubMed Web of Science ®Google Scholar
• CamposMAvilaMWallauAEfficacy and tolerability of a fixed-dose moxifloxacin-dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trialClin Ophthalmol20082233133819668724
   PubMedGoogle Scholar